Article · 30 Apr 2025
Case reportPublished 29 Apr 2023
Case report: Intranasal Spravato (Esketamine) use in treatment-resistant major depressive disorder in a patient with significant psychosocial stressors
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Millions of people in the US are affected by depression which causes a significant decrease in quality of life and daily functioning for affected individuals. In many cases, depression persists despite multiple treatments, and medical professionals are always looking for new methods to alleviate the burden of depression. Our case report describes an observation of Spravato treatment in a patient with treatment-resistant depression who has a history of significant psychosocial stressors. Psychosocial factors can play a significant role in treatment outcomes for patients across different fields of medicine. Helping the patient to build effective coping skills to deal with life stressors and to find adequate social support could positively contribute to successful treatment of the disease.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Investigation.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Investigation
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Anastasia Masle”
- BylineArticles whose byline prints “Teresa Canova”
- BylineArticles whose byline prints “Gabriel Martinez”